Search Results

There are 3002269 results for: content related to: Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6)

  1. Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin-linked Parkinson's disease

    Movement Disorders

    Volume 21, Issue 3, March 2006, Pages: 299–305, Michele T.M. Hu, Christoph Scherfler, Naheed L. Khan, Jo V. Hajnal, Andrew J. Lees, Niall Quinn, Nicholas W. Wood and David J. Brooks

    Article first published online : 6 OCT 2005, DOI: 10.1002/mds.20702

  2. Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: An 18F-dopa PET progression study

    Movement Disorders

    Volume 24, Issue 15, 15 November 2009, Pages: 2260–2266, Nicola Pavese, Naheed L. Khan, Christoph Scherfler, Lisa Cohen, David J. Brooks, Nicholas W. Wood, Kailash P. Bhatia, Niall P. Quinn, Andrew J. Lees and Paola Piccini

    Article first published online : 20 OCT 2009, DOI: 10.1002/mds.22817

  3. Milestones in neuroimaging

    Movement Disorders

    Volume 26, Issue 6, May 2011, Pages: 868–978, A. Jon Stoessl, David J. Brooks and David Eidelberg

    Article first published online : 27 MAY 2011, DOI: 10.1002/mds.23679

  4. Dopaminergic function in familial Parkinson's disease: A clinical and 18F-dopa positron emission tomography study

    Annals of Neurology

    Volume 41, Issue 2, February 1997, Pages: 222–229, Dr P. Piccini, P. K. Morrish, N. Turjanski, G. V. Sawle, D. J. Burn, R. A. Weeks, M. H. Mark, D. M. Maraganore, A. J. Lees and D. J. Brooks

    Article first published online : 8 OCT 2004, DOI: 10.1002/ana.410410213

  5. PET/CT in diagnosis of movement disorders

    Annals of the New York Academy of Sciences

    Volume 1228, Issue 1, June 2011, Pages: 93–108, Valentina Berti, Alberto Pupi and Lisa Mosconi

    Article first published online : 30 JUN 2011, DOI: 10.1111/j.1749-6632.2011.06025.x

  6. Imaging end points for monitoring neuroprotection in Parkinson's disease

    Annals of Neurology

    Volume 53, Issue S3, 2003, Pages: S110–S119, David J. Brooks

    Article first published online : 24 MAR 2003, DOI: 10.1002/ana.10480

  7. Parkinsonism associated with acute intracranial hematomas: An [18F]dopa positron-emission tomography study

    Movement Disorders

    Volume 12, Issue 6, November 1997, Pages: 1035–1038, Dr. Nora Turjanski, Brian Pentland, Andrew J. Lees and David J. Brooks

    Article first published online : 4 NOV 2004, DOI: 10.1002/mds.870120630

  8. Do dopamine agonists or levodopa modify Parkinson's disease progression?

    European Journal of Neurology

    Volume 9, Issue s3, November 2002, Pages: 15–22, K. Marek, D. Jennings and J. Seibyl

    Article first published online : 11 DEC 2002, DOI: 10.1046/j.1468-1331.9.s3.2.x

  9. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

    Annals of Neurology

    Volume 54, Issue 1, July 2003, Pages: 93–101, Alan L. Whone, Ray L. Watts, A. Jon Stoessl, Margaret Davis, Sven Reske, Claude Nahmias, Anthony E. Lang, Olivier Rascol, Maria J. Ribeiro, Philippe Remy, Werner H. Poewe, Robert A. Hauser and David J. Brooks

    Article first published online : 14 MAY 2003, DOI: 10.1002/ana.10609

  10. Use of functional imaging in parkinsonism and dementia

    Movement Disorders

    Volume 18, Issue S6, September 2003, Pages: 88–95, David J. Burn and John T. O'Brien

    Article first published online : 4 SEP 2003, DOI: 10.1002/mds.10568

  11. Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?

    Movement Disorders

    Volume 18, Issue S7, October 2003, Pages: S43–S51, Walter Pirker

    Article first published online : 26 SEP 2003, DOI: 10.1002/mds.10579

  12. 18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease

    Synapse

    Volume 43, Issue 3, 1 March 2002, Pages: 201–207, Roberto Ceravolo, Paola Piccini, Dale L. Bailey, Karin M. Jorga, Helen Bryson and David J. Brooks

    Article first published online : 14 DEC 2001, DOI: 10.1002/syn.10034

  13. 18F-FDG and new positron emitter radiotracers for detecting recurrent medullary thyroid carcinoma

    Journal of Medical Imaging and Radiation Oncology

    Volume 56, Issue 2, April 2012, Pages: 132–135, MARIA CRISTINA MARZOLA and DOMENICO RUBELLO

    Article first published online : 13 APR 2012, DOI: 10.1111/j.1754-9485.2012.02353.x

  14. Comparison of [111In]pentetreotide-SPECT and [18F]FDOPA-PET in the localization of extra-adrenal paragangliomas: the case for a patient-tailored use of nuclear imaging modalities

    Clinical Endocrinology

    Volume 74, Issue 1, January 2011, Pages: 21–29, N. Charrier, A. Deveze, N. Fakhry, F. Sebag, I. Morange, B. Gaborit, A. Barlier, E. Carmona, C. De Micco, S. Garcia, J. Mancini, F. F. Palazzo, J. P. Lavieille, M. Zanaret, J. F. Henry, O. Mundler and D. Taïeb

    Article first published online : 15 DEC 2010, DOI: 10.1111/j.1365-2265.2010.03893.x

  15. Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease

    Movement Disorders

    Volume 21, Issue 1, January 2006, Pages: 94–98, Katherine J. Schweitzer, Rüdiger Hilker, Uwe Walter, Lothar Burghaus and Daniela Berg

    Article first published online : 19 AUG 2005, DOI: 10.1002/mds.20669

  16. Molecular imaging in hereditary forms of parkinsonism

    European Journal of Neurology

    Volume 14, Issue 4, April 2007, Pages: 359–368, M. C. Shih, A. C. Felicio, C. De Oliveira Godeiro-Junior, P. De Carvalho Aguiar, L. A. F. De Andrade, H. B. Ferraz and R. A. Bressan

    Article first published online : 23 MAR 2007, DOI: 10.1111/j.1468-1331.2007.01691.x

  17. Dopamine agonists and Parkinson's disease progression: What can we learn from neuroimaging studies

    Annals of Neurology

    Volume 53, Issue S3, 2003, Pages: S160–S169, Kenneth Marek, Danna Jennings and John Seibyl

    Article first published online : 24 MAR 2003, DOI: 10.1002/ana.10486

  18. Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: An 18F-dopa PET study

    Annals of Neurology

    Volume 52, Issue 6, December 2002, Pages: 849–853, Naheed L. Khan, Enza Maria Valente, Anna Rita Bentivoglio, Nicholas W. Wood, Alberto Albanese, David J. Brooks and Paola Piccini

    Article first published online : 22 NOV 2002, DOI: 10.1002/ana.10417

  19. Value of combined 6-[18F]fluorodihydroxyphenylalanine PET/CT for imaging of neuroendocrine tumours

    British Journal of Surgery

    Volume 97, Issue 5, May 2010, Pages: 691–697, M. Schiesser, P. Veit-Haibach, M. K. Muller, M. Weber, P. Bauerfeind, T. Hany and P.-A. Clavien

    Article first published online : 11 MAR 2010, DOI: 10.1002/bjs.6937

  20. Structural findings in the basal ganglia in genetically determined and idiopathic Parkinson's disease

    Movement Disorders

    Volume 24, Issue 1, 15 January 2009, Pages: 99–103, Kathrin Reetz, Christian Gaser, Christine Klein, Johannes Hagenah, Christian Büchel, Stefan Gottschalk, Peter P. Pramstaller, Hartwig R. Siebner and Ferdinand Binkofski

    Article first published online : 29 SEP 2008, DOI: 10.1002/mds.22333